Search Results - "Takasawa, Kei"

Refine Results
  1. 1

    Endocrinopathies in Inborn Errors of Immunity by Takasawa, Kei, Kanegane, Hirokazu, Kashimada, Kenichi, Morio, Tomohiro

    Published in Frontiers in immunology (23-11-2021)
    “…Inborn errors of immunity (IEI), caused by hereditary or genetic defects, are a group of more than 400 disorders, in which the immune system, including…”
    Get full text
    Journal Article
  2. 2

    Current status of transition medicine for 21-hydroxylase deficiency in Japan: from the perspective of pediatric endocrinologists by Takasawa, Kei, Nakamura-Utsunomiya, Akari, Amano, Naoko, Ishii, Tomohiro, Hasegawa, Tomonobu, Hasegawa, Yukihiro, Tajima, Toshihiro, Ida, Shinobu

    Published in ENDOCRINE JOURNAL (01-01-2022)
    “…To manage of 21-hydroxylase deficiency (21-OHD), transition medicine from pediatric to adult health care is an important process and requires individually…”
    Get full text
    Journal Article
  3. 3

    Toward Improving the Transition of Patients With Congenital Adrenal Hyperplasia From Pediatrics to Adult Healthcare in Japan by Takasawa, Kei, Kashimada, Kenichi

    Published in Frontiers in pediatrics (21-06-2022)
    “…The transition of patients with childhood-onset chronic diseases from pediatric to adult healthcare systems has recently received significant attention. Since…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan by Yatsuga, Shuichi, Amano, Naoko, Nakamura-Utsunomiya, Akari, Kobayashi, Hironori, Takasawa, Kei, Nagasaki, Keisuke, Nakamura, Akie, Nishigaki, Satsuki, Numakura, Chikahiko, Fujiwara, Ikuma, Minamitani, Kanshi, Hasegawa, Tomonobu, Tajima, Toshihiro

    Published in ENDOCRINE JOURNAL (01-01-2020)
    “…Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis that causes various symptoms such as skeletal malformations, disorders of sex…”
    Get full text
    Journal Article
  8. 8

    Prematurity at less than 24 weeks of gestation is a risk for prolonged hyperglycemia in extremely low-birth weight infants by Yamauchi, Takeru, Imamura, Masatoshi, Takasawa, Kei, Nakajima, Keisuke, Nakagawa, Ryuichi, Gau, Maki, Sugie, Manabu, Taki, Atsuko, Kawai, Masahiko, Kashimada, Kenichi, Morio, Tomohiro

    Published in Endocrine (01-10-2020)
    “…Hyperglycemia in extremely low-birth weight infants (ELBWIs) is frequently observed during the acute perinatal phase, (i.e., first 1–2 weeks postnatal period);…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Potential pathological role of single nucleotide polymorphism (c.787T>C) in alkaline phosphatase (ALPL) for the phenotypes of hypophosphatasia by Matsuda, Nozomi, Takasawa, Kei, Ohata, Yasuhisa, Takishima, Shigeru, Kubota, Takuo, Ishihara, Yasuki, Fujiwara, Makoto, Ogawa, Erika, Morio, Tomohiro, Kashimada, Kenichi, Ozono, Keiichi

    Published in ENDOCRINE JOURNAL (01-01-2020)
    “…Hypophosphatasia (HPP; OMIM 241510, 241500, and 146300) is an inherited metabolic disease characterized by defects of bone and tooth mineralization, which is…”
    Get full text
    Journal Article
  11. 11

    Marked clinical heterogeneity in congenital hyperinsulinism due to a novel homozygous ABCC8 mutation by Takasawa, Kei, Miyakawa, Yuichi, Saito, Yoko, Adachi, Eriko, Shidei, Tsunanori, Sutani, Akito, Gau, Maki, Nakagawa, Ryuichi, Taki, Atsuko, Kashimada, Kenichi, Morio, Tomohiro

    Published in Clinical endocrinology (Oxford) (01-06-2021)
    “…Background The most severe forms of congenital hyperinsulinism (CHI) are caused by inactivating mutations of two KATP channel genes, KCNJ11 and ABCC8…”
    Get full text
    Journal Article
  12. 12

    Central diabetes insipidus developing in a 6-year-old patient 4 years after the remission of unifocal bone Langerhans cell histiocytosis by Nakatani, Hisae, Takasawa, Kei, Kashimada, Kenichi, Morimoto, Akira, Oshiba, Akihiro, Nagasawa, Masayuki

    Published in Clinical Pediatric Endocrinology (2021)
    “…A six-year-old boy was referred with a one-and-a-half months history of polyuria and polydipsia. At the age of two, he had a single lytic bone lesion in his…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus by Nagatsuma, Misako, Takasawa, Kei, Yamauchi, Takeru, Nakagawa, Ryuichi, Mizuno, Tomoko, Tanaka, Eriko, Yamamoto, Kouhei, Uemura, Noriko, Kashimada, Kenichi, Morio, Tomohiro

    Published in Journal of human genetics (01-02-2019)
    “…Schimmelpenning syndrome is a rare neurocutaneous disorder categorized as a mosaic RASopathy due to postzygotic HRAS or KRAS mutations. We report a 6-year-old…”
    Get full text
    Journal Article
  18. 18

    Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care by Acerini, Carlo L, Segal, David, Criseno, Sherwin, Takasawa, Kei, Nedjatian, Navid, Röhrich, Sebastian, Maghnie, Mohamad

    Published in Frontiers in endocrinology (Lausanne) (22-11-2018)
    “…Several studies have shown that adherence to growth hormone therapy (GHT) is not optimal. There are several reasons why patients may not fully adhere to their…”
    Get full text
    Journal Article
  19. 19

    A novel variant of NR5A1, p.R350W implicates potential interactions with unknown co-factors or ligands by Gau, Maki, Suga, Ryota, Hijikata, Atsushi, Kashimada, Ayako, Takagi, Masatoshi, Nakagawa, Ryuichi, Takasawa, Kei, Shirai, Tsuyoshi, Kashimada, Kenichi, Morio, Tomohiro

    Published in Frontiers in endocrinology (Lausanne) (20-01-2023)
    “…NR5A1 and NR5A2 belong to an orphan nuclear receptor group, and approximately 60% of their amino acid sequences are conserved. Transcriptional regulation of…”
    Get full text
    Journal Article
  20. 20